However, further progression to CMML-like or AML-like phenotypes was observed only in some mutants, suggesting that asxl1 mutations alone are sufficient for MDS-SLD but not for severe myeloid malignancies, with other events responsible for progression. This evidence concerns the gene ASXL1 and myelodysplastic syndrome.